Zum Inhalt springen
Endothelzellen der menschlichen Vena saphena (HSVEC)
Gewebe
Saphenous vein
Krankheit
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastasenherd
Not applicable (normal, non-tumorigenic primary cell)
Synonyme
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Dokumente

Endothelzellen der menschlichen Vena saphena (HSVEC)

Primary cell · Artikelnummer 300699

Venous endothelium for bypass graft research

€1,220.00zzgl. MwSt. und Versandkosten

Anpassung / Empfehlungen

Auftragsfertigung
1

01Allgemeine Informationen

Beschreibung

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Gewebe
Saphenous vein
Krankheit
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastasenherd
Not applicable (normal, non-tumorigenic primary cell)
Anwendungen
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Synonyme
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Spender

Alter des Spenders
Lot-specific (see CoA)
Ethnische Zugehörigkeit
Lot-specific (see CoA)

03Klassifizierung

Organismus
Mensch
Sex
Los-spezifisch
Wachstumseigenschaften
Anhänger
GVO-Status
Ohne Gentechnik
Angaben zum GVO-Status
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Biologische Sicherheitsstufe
1

04Merkmale

Morphologie
Cobblestone (endothelial)
Zelltyp
Primary endothelial cells
Tumorauslösend
No
Verdopplungszeit
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Handhabung und Kultur

Nährmedium
Endothelial Cell Growth Medium
Inkubationsatmosphäre

37°C, 5% CO2, saturated humidity.

Nahrungsergänzungsmittel
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Dissoziationsreagenz
Subculture reagents as recommended on the certificate of analysis
Flaschenbeschichtung
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Subkultivierung

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Split-Verhältnis
1 to 3
Aussaatdichte
More than 6,000 cells/cm²
Flüssigkeitswechsel
24 hours after seeding, then every 48 to 72 hours
Erholung nach dem Auftauen

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Auftauen und Kultivierung
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Qualitätskontrolle und Kryokonservierung

Sterilität

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Gefriermedium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Lagerbedingungen

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Versandbedingungen

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Expression und Anfälligkeit

Oberflächenantigene
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Exprimierte Rezeptoren
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Bezeichner

Quellenangabe
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI-Steuer-ID
9606
Cellosaurus
Not assigned